Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1, first-in-human study of CUSP06, a cadherin-6 (CDH6) -directed antibody-drug conjugate, in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors
    Meeting Abstract

    Spira, A. I.; Lee, E. K.; O'Cearbhaill, R. E.; LoRusso, P.; Falchook, G. S.; Patel, M. R.; Richardson, D. L.; Lu, W.; Marreddy, P.; Farrington, D. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Association of machine learning (ML)-derived histological features with transcriptomic molecular subtypes in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Beig, N.; Nofallah, S.; McDermott, D. F.; Motzer, R. J.; Powles, T.; Rini, B. I.; Koeppen, H.; Banchereau, R.; Markey, M.; Finberg, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multi-institution real world analysis of patients with non-small cell lung cancer (NSCLC) treated with standard of care (SOC) neoadjuvant chemo-immunotherapy (chemoIO)
    Meeting Abstract

    Cooper, A. J.; Gorria, T.; Conroy, M. R.; Ricciuti, B.; Pecci, F.; Aldea, M.; Anagnostou, V.; Shaverdian, N.; Bott, M.; Forde, P. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Chiu, C. F.; Piscaglia, F.; Sangro, B.; Henkel, A.; Fang, H.; Patel, M.; Ping, Z.; Sutherland, C.; Bako, E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 ((225)Ac) -labeled antibody targeting human kallikrein 2 (hK2), for metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Wong, J. Y. C.; Nordquist, L.; Szmulewitz, R. Z.; Agarwal, N.; Attiyeh, E. F.; Max, S. I.; Divgi, C. R.; Patricia, D.; Cao, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alignment of patient-clinician perspectives in triple-negative breast cancer (TNBC)
    Meeting Abstract

    Ackbarali, T.; Goins, C.; Walker, S.; Donahue, S.; Witt, J.; Vidal, G. A.; Traina, T. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial
    Meeting Abstract

    Shergill, A.; Liao, C. Y.; Elsaid, M. I.; Al Baghdadi, T.; Ji, Y.; Feldman, D.; George, S.; O'Reilly, E. M.; Meyerhardt, J. A.; Berg, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A clinical-genetic (CG) circulating tumor DNA (ctDNA)-based prognostic model for predicting overall survival (OS) in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with potent androgen receptor inhibition (Alliance)
    Meeting Abstract

    Halabi, S.; Luo, B.; Guo, S. S.; Knutson, T.; Lyman, J.; Kobilka, A.; Beltran, H.; Antonarakis, E. S.; Rosenberg, J. E.; Galsky, M. D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b study evaluating the efficacy and safety of ABBV-400, a c-Met-targeting antibody-drug conjugate, in select advanced solid tumor indications
    Meeting Abstract

    Perets, R.; Sharma, M.; Strickler, J. H.; Golan, T.; Hollebecque, A.; Henner, W.; Vasilopoulos, A.; Thiele, G. M.; Burns, M. C.; Harding, J. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of ADT interruption in patients responding exceptionally to AR-pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM/Alliance A032101)
    Meeting Abstract

    Choudhury, A. D.; Heller, G.; Reimers, M. A.; Laccetti, A. L.; Smieliauskas, F.; Ravi, P.; Dooley, K.; Mazza, G. L.; Gartrell, B. A.; Steen, P. D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save